What We Do
Leading Player in the Pharmaceutical Industry
Kadamb Pharmaceuticals is a leading player in the pharmaceutical industry, specializing in the production of Valproic acid and its salts, alongside a comprehensive range of intermediates. With a strong emphasis on quality, innovation, and competitive pricing, Kadamb has positioned itself as a trailblazer in the field, driven by its state-of-the-art in-house Research and Development (R&D) setup.
At the core of Kadamb’s mission is the relentless pursuit of producing Valproic acid and its derivatives of the highest caliber. Valproic acid, a versatile compound known for its therapeutic applications, has garnered immense attention in the medical community for its effectiveness in treating various neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. The pharmaceutical industry’s growing demand for Valproic acid and its derivatives has paved the way for Kadamb to establish itself as a significant global player. Here are our values:
- Commitment to Excellence
- Optimized Production Processes
- Steadfast Commitment to Quality
- Determination to Scale New Heights
What Makes Us Different
One of Kadamb's key differentiators lies in its robust in-house R&D setup. Our dedicated team of skilled scientists and researchers work tirelessly to innovate and optimize production processes, ensuring that our products meet the most stringent quality standards. By leveraging cutting-edge technologies and methodologies, we are able to consistently deliver superior quality Valproic acid and its salts to our clients. This commitment to excellence has solidified Kadamb's reputation as a trusted partner in the pharmaceutical supply chain.
Dedicated Plant for Valproic Acid and its Salts
There is zero chance of cross contamination, as all equipment is allocated to individual steps, and the entire facility is purposefully designed solely for the production of these products.
End to End Product Manufacturing
Manufacturing from fundamental chemicals, which allows for comprehensive control over both quality and pricing. At the heart of this strategy lies the ability to exercise rigorous supervision over product quality.
Fastest Growing API Manufacturing Company
Approved with more than 3 US-FDA approved plant for supplying KSM of Divalproex sodium. This solidifies its position in the market as a key player dedicated to quality, innovation, and reliability in API manufacturing.